FSC sent FDA warning letter for lacking CMO quality agreement
The US FDA has sent FSC Laboratories a warning letter for failing to set up a quality agreement with its contract manufacturer.
The US FDA has sent FSC Laboratories a warning letter for failing to set up a quality agreement with its contract manufacturer.
Inclinix has teamed up with JSW Life Sciences in a bid to ramp up its European patient recruitment capabilities.
Unilife is expanding its large dose delivery platform in a bid to meet a “growing industry need” for at-home drug administration in bigger scale.
Brecon Pharmaceuticals has opened a new storage facility for clinical trial supplies citing higher demand following its partnership with Anderson.
The US FDA has published draft guidance on drug shortages to clarify when and how manufacturers should report possible supply disruptions.
Premier Research has doubled its clinical trials testing capacity with the launch of two research facilities in Phoenix and Salt Lake City, US.
The US FDA has issued import alerts against 22 Chinese heparin suppliers it claims ship adulterated product.
S&P is predicting up to high single-digit near-term growth at Quintiles but rising costs and early phase capacity issues will pressure profits.